MVM PARTNERS, LLC
MVM PARTNERS, LLC is a Seed, Series A, Series B and Series C+ fund in the US and Europe writing $20M–$100M checks into Healthcare, healthcare-tech, life-sciences, medical-devices, pharmaceuticals, diagnostics, health-it, life-science-tools, contract-research and contract-manufacturing.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, healthcare-tech, life-sciences, medical-devices, pharmaceuticals, diagnostics, health-it, life-science-tools, contract-research, contract-manufacturing
- Check size
- $20M–$100M
- Invests in
- US-wide, Europe
- Actively investing
- Yes
- Founded
- 1997
- Assets under management
- $1B+
Thesis
MVM Partners is a growth equity firm founded in 1997, specializing in the healthcare and life sciences sectors. With over $1 billion in assets under management and offices in Boston and London, they focus on companies with innovative products addressing significant unmet needs in large markets. Their investment strategy targets later-stage companies (seed to growth equity) with high growth potential and durable competitive advantages, often through intellectual property or market entry barriers. They typically invest $20 million to $100 million per company, partnering with management to drive growth and acquisitions. Their sector focus is broad within healthcare, including medical devices, pharmaceuticals, diagnostics, digital health, life science tools, and contract services. MVM Partners is a registered investment adviser.
Common questions
Does MVM PARTNERS, LLC invest at the Seed stage?
Yes. MVM PARTNERS, LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does MVM PARTNERS, LLC write?
MVM PARTNERS, LLC writes $20M–$100M checks.
Where does MVM PARTNERS, LLC invest?
MVM PARTNERS, LLC invests in the US and Europe.